All In Biotech

Drug Trial Radar · NCT02318368

A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label

A Phase 2, Multicenter, Randomized, Double-blind Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label

Last checked: Nov 20, 2026Latest source record: Oct 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

10

Actual

Start

Nov 2014

Primary completion

Jan 2017

Study completion Jan 2017

Sponsor

Lead sponsor
AVEO Pharmaceuticals, Inc.Industry
Sponsor type
Industry
Collaborators
Biodesix, Inc.
First posted
Dec 17, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 2 multicenter, controlled, randomized, double-blind study to evaluate the efficacy and safety of ficlatuzumab versus placebo when administered with erlotinib in subjects with previously untreated metastatic EGFR-mutated NSCLC and BDX004 Positive Label.

Conditions

  • Non-small Cell Lung Cancer

Interventions

  • FiclatuzumabDrug

  • ErlotinibDrug

  • placeboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression Free Survival (PFS)Time frame: Approximately 24 months

Locations

47 sites in 7 countries. Site status is shown where the registry gives one.

  • UCSF Fresno

    Fresno, California

  • Torrance Memorial Medical Center

    Redondo Beach, California

  • Boca Raton Regional Hospital Lynn Cancer Institute

    Boca Raton, Florida

  • University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach

    Deerfield Beach, Florida

  • Kaiser Permanente Hawaii

    Honolulu, Hawaii

  • Cancer Center of Acadiana

    Lafayette, Louisiana

  • Mayo Clinic

    Rochester, Minnesota

  • Valley Medical Group

    Paramus, New Jersey

  • Queens Hospital Cancer Center

    Jamaica, New York

  • Aultman Hospital

    Canton, Ohio

  • Gabrail Cancer Center

    Canton, Ohio

  • UPMC Cancer Center Cancer

    Pittsburgh, Pennsylvania

  • Huntsman Cancer Institute

    Salt Lake City, Utah

  • Chris O'Brien Lifehouse

    Camperdown, New South Wales, Australia

  • North Coast Cancer Institute

    Coffs Harbour, New South Wales, Australia

  • Concord Repatriation General Hospital

    Concord, New South Wales, Australia

  • Townsville Hospital

    Douglas, Queensland, Australia

  • Icon Cancer Care

    Southport, Queensland, Australia

  • Princess Alexandra Hospital

    Wolloongabba, Queensland, Australia

  • Flinders Medical Centre

    Bedford Park, South Australia, Australia

  • Eastern Health

    Box Hill, Victoria, Australia

  • Frankston Hospital

    Frankston, Victoria, Australia

  • Ballarat Oncology and Haematology

    Wendouree, Victoria, Australia

  • Queen Mary Hospital

    Pok Fu Lam, Hong Kong

  • Tuen Mun Hospital

    Tuenmen, N.T, Hong Kong

  • AO G.Rummo

    Benevento, Italy

  • Policlinico S.Orsola Malpighi

    Bologna, Italy

  • Istituti Ospitalieri di Cremona - Oncologia

    Cremona, Italy

  • U.O.C. Oncologia

    Lucca, Italy

  • IRCCS Ospedale S.Raffaele

    Milan, Italy

  • Fondazione Salvatore Maugeri

    Pavia, Italy

  • IRCCS Istituto Clinico Humanitas

    Rozzano MI, Italy

  • Ospedale Treviglio-Caravaggio

    Treviglio BG, Italy

  • John Hopkins Singapore International Medical Center

    Central Singapore, Singapore

  • National Cancer Centre

    Singapore, Singapore

  • Chungbuk National University Hospital

    Chungcheongbuk-do, South Korea

  • Chonnam National University Hwasun Hospital

    Jeonnam, South Korea

  • Severance Hospital, Yonsei Uni

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Korea University Guro Hospital

    Guro-gu, Seoul, South Korea

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.